External validation of a nomogram for unilateral pelvic lymph node dissection in prostate cancer
The Briganti 2019 nomogram outperformed the novel unilat-NG in contralateral LNI prediction. Yet, a significant proportion of patients undergoing unilateral ePLND would be falsely classified with pN0 disease using any of the nomograms. Therefore, bilateral ePLND should remain the standard of care if PLND is indicated.
Authors
- Markus Graefen
- Fabian Falkenbach (ORCID: https://orcid.org/0000-0003-1907-3982)
- Mykyta Kachanov (ORCID: https://orcid.org/0000-0001-6543-0309)
- Lars Budäus
- Tobias Maurer (ORCID: https://orcid.org/0000-0002-5660-7691)
- Gernot Ortner (ORCID: https://orcid.org/0000-0002-2454-6599)
- Sophie Knipper (ORCID: https://orcid.org/0000-0002-2681-3611)
- Tim Inderhees
Institutions
- Universität Hamburg (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Vivantes Klinikum (DE)
- Martini-Klinik (DE)
- Tirol Kliniken (AT)
Publication Details
- Journal
- British Journal of Urology
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1111/bju.16687
- Citations
- 1
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52